Pharmacology and Pharmacokinetics of Vitamin E: Nanoformulations to Enhance Bioavailability
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Vitamin E belongs to the family of lipid-soluble vitamins and can be divided into two groups, tocopherols and tocotrienols, with four isomers (alpha, beta, gamma and delta). Although vitamin E is widely known as a potent antioxidant, studies have also revealed that vitamin E possesses anti-inflammatory properties. These crucial properties of vitamin E are beneficial in various aspects of health, especially in neuroprotection and cardiovascular, skin and bone health. However, the poor bioavailability of vitamin E, especially tocotrienols, remains a great limitation for clinical applications. Recently, nanoformulations that include nanovesicles, solid-lipid nanoparticles, nanostructured lipid carriers, nanoemulsions, and polymeric nanoparticles have shown promising outcomes in improving the efficacy and bioavailability of vitamin E. This review focuses on the pharmacological properties and pharmacokinetics of vitamin E and current advances in vitamin E nanoformulations for future clinical applications. The limitations and future recommendations are also discussed in this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Challenges in Development of Nanoparticle-Based Therapeutics
Desai, N. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9339-4 · Cited by 1,173 · cited 1×
“Nanoformulations offer many advantages, including improved efficacy of active pharmaceutical ingredients, biocompatibility, reduced toxicity and enhanced bioavailability due to the small size and large surface area.(62) Compared to the other approaches mentioned above, nanoformulations appear to offer a wider range of…”
BackgroundGiraldo, E., Lloret, A., Fuchsberger, T., & Viña, J. (2014) · Redox Biology · doi:10.1016/j.redox.2014.03.002 · Cited by 268 · cited 1×
“In animal models of AD, vitamin E was found to reduce the progression of the disease by inhibiting p38 signalling pathway activation, which prevents amyloid beta (Aβ)-induced tau hyperphosphorylation.(18) On the Figure 1 Chemical structures of tocopherol and tocotrienol.”
BackgroundDietary antioxidants and risk of Parkinson's disease in two population-based cohorts
Yang, F., Wolk, A., Håkansson, N., Pedersen, N. L., & Wirdefeldt, K. (2017) · Movement Disorders · doi:10.1002/mds.27120 · Cited by 116 · cited 1×
“of vitamin E and β-carotene was associated with a low risk of the disease.(20) Vitamin E, especially tocotrienols, has also been studied thoroughly for its potential in preventing metabolic syndrome and cardiovascular diseases (CVDs).”
BackgroundMontagnani Marelli, M., Marzagalli, M., Moretti, R. M., Beretta, G., Casati, L., Comitato, R., Gravina, G. L., Festuccia, C., & Limonta, P. (2016) · Scientific Reports · doi:10.1038/srep30502 · Cited by 74 · cited 1×
“Another study on mouse melanoma xenografts showed that δ-tocotrienol treatment (100 mg/kg) significantly reduced the tumour volume and delayed tumour progression.(39) Vitamin E, especially tocotrienols, is beneficial in improving bone strength by inducing bone formation and osteoblast (bone-forming cells) activity, as…”
BackgroundChoi, B., Heo, J. H., Kwon, H. J., Lee, E.-S., & Sohn, S. (2013) · Food & Function · doi:10.1039/c3fo60289c · Cited by 12 · cited 1×
“This is due to the increased expression of endosome docking/fusion proteins, which contributes to the degradation of melanosomes by docking to lysosomes.(30) Vitamin E has been proven to provide excellent skin protection when used in combination with other antioxidants.”
Background
Metadata
- Authors
- Mohd Zaffarin, A. S., Ng, S.-F., Ng, M. H., Hassan, H., & Alias, E.
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2020-12
- Volume
- Volume 15
- Pages
- 9961-9974
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- OpenAlex
- W3112600702
- Cited by
- 167
- References
- 5
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.